RARoomana Ali

Roomana Ali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roomana Ali has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis

    by Maryam Gul, Sajid Ali, Abdul Rehman, Muhammad Qasim, Roomana Ali, Jody E. Phelan, Aiman Waheed, Sajjad Ahmad, Mubbashir Hussain, Susana Campino, et al.

    Background: Resistance to first-line anti-tuberculosis drugs in Mycobacterium tuberculosis represents a significant public health challenge, particularly in high-burden tuberculosis (TB) settings such as Pakistan, where multidrug-resistant (MDR) forms further complicate disease control efforts. Drug resistance is primarily associated with mutations in rpoB, inhA, katG, embA, embB, embC, and pncA. The emergence of novel, region-specific variants underscores the urgent need for integrating genomic surveillance into routine TB diagnostics and regional control programs. This study aimed to identify the spectrum of mutations contributing to first-line drug resistance in MDR-TB isolates from Khyber Pakhtunkhwa, Pakistan. Methods: Whole-genome sequencing was performed on 16 clinical isolates (12 MDR and 4 drug-susceptible) to identify resistance-associated mutations in rpoB, inhA, katG, embA, embB, embC, and pncA. Detected variants were interpreted using the World Health Organization (WHO) mutation catalogue to determine their association with drug resistance. Phylogenetic relationships were inferred using the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) platform. Results: A total of 16 M. tuberculosis isolates were analyzed to evaluate resistance to first-line anti-tuberculosis drugs. In rpoB, 76 distinct variants were identified, including canonical mutations such as Ser450Leu and His445Arg, as well as a potentially novel substitution, Ser431Phe, predicted to confer high-level rifampicin resistance. The katG and inhA genes harbored 24 and 27 mutations, respectively, including well-characterized substitutions such as Ser315Thr and Ala114Glu, which are strongly associated with isoniazid resistance. Mutations in embA and embB were linked to ethambutol resistance, with several variants localized within conserved transmembrane domains critical for drug interaction. Phylogenetic analysis revealed substantial genetic diversity and evidence of local transmission among MDR-TB isolates. Conclusions: This study suggests that the genetic landscape of drug resistance in M. tuberculosis is highly dynamic in endemic regions. The findings highlight the importance of integrating region-specific mutation profiles into molecular diagnostic frameworks to enhance early detection, guide individualized therapeutic interventions, and strengthen strategies aimed at controlling the transmission of MDR-TB.


  • Host associated probiotics Lactobacillus reuteri and Enterococcus faecium Mitigate multidrug resistant Salmonella enterica in broiler chicks

    by Abubakar Siddique, Roomana Ali, Saadia Andleeb, Samina Akbar, Zeeshan Hafeez, Muhammad Imran, Emily Van Syoc, Min Yue, Erika Ganda, Abdur Rahman


  • Open Access

    “Investigating Colistin Resistance in Carbapenem Resistant Acinetobacter baumanii Isolates during a Neonatal Intensive Care Unit outbreak "

    by Mubashir Raza, Saadullah Jan Khan, Muhammad Faisal Masood., Laila Jafri, Rehana Rani, Roomana Ali, Sara Sadiq, Nosheen Aakhtar, Bushra Jamil

    Purpose: Colistin resistant Acinetobacter baumannii poses a growing challenge in neonatal intensive care units (NICUs) due to the emergence of plasmid-mediated Mobile Colistin Resistance (mcr) genes that can rapidly spread among neonates. This pioneering study conducted a comprehensive analysis of mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5 genes in A. baumannii strains isolated from NICU. Notably, this investigation marks the first of its kind in this setting. In addition to genotypic analyses, the study incorporated phenotypic assays to identify the most effective method for detecting colistin resistance in these A. baumannii strains. Methods: In the genotypic investigation, DNA was extracted from strains of colistin-resistant A. baumannii, collected from the NICU of a local hospital of Islamabad, Pakistan. The specific set of primers for each mcr gene was used to detect their presence. Various phenotypic methods such as, disc diffusion, broth macro dilution, Minimum Inhibitory Concentration (MIC), disc elusion and colistin agar methods were performed using predetermined calculations for phenotypic studies. Results:The study confirms the distribution of the mcr-1 gene among the eight strains, which contributes 62% of the total number, whereas mcr-2, 3, 4 and 5 genes were not detected in all strains. Based on phenotypic analysis, A. baumannii had shown resistance against colistin at < 2µg/mL. In contrast, MIC varies from strain to strain. Conclusions: The horizontal transfer of the mcr-1 gene is responsible for developing resistance against colistin among A. baumannii in neonates. All phenotypic methods adopted in this study generated the same results, so the method selection depends upon individual comfort. However, we propose that the colistin agar method offers multiple advantages over other methods as it is more economical, easy to perform, multiple samples can be assessed simultaneously, and fewer calculations are involved for colistin resistance determination and finding out clinical breakpoints.

  • Open Access

    “Investigating Colistin Resistance in Carbapenem Resistant Acinetobacter baumanii Isolates during a Neonatal Intensive Care Unit outbreak "

    by Mubashir Raza, Saadullah Jan Khan, Muhammad Faisal Masood., Laila Jafri, Rehana Rani, Roomana Ali, Sara Sadiq, Nosheen Aakhtar, Bushra Jamil

    Purpose: Colistin resistant Acinetobacter baumannii poses a growing challenge in neonatal intensive care units (NICUs) due to the emergence of plasmid-mediated Mobile Colistin Resistance (mcr) genes that can rapidly spread among neonates. This pioneering study conducted a comprehensive analysis of mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5 genes in A. baumannii strains isolated from NICU. Notably, this investigation marks the first of its kind in this setting. In addition to genotypic analyses, the study incorporated phenotypic assays to identify the most effective method for detecting colistin resistance in these A. baumannii strains. Methods: In the genotypic investigation, DNA was extracted from strains of colistin-resistant A. baumannii, collected from the NICU of a local hospital of Islamabad, Pakistan. The specific set of primers for each mcr gene was used to detect their presence. Various phenotypic methods such as, disc diffusion, broth macro dilution, Minimum Inhibitory Concentration (MIC), disc elusion and colistin agar methods were performed using predetermined calculations for phenotypic studies. Results:The study confirms the distribution of the mcr-1 gene among the eight strains, which contributes 62% of the total number, whereas mcr-2, 3, 4 and 5 genes were not detected in all strains. Based on phenotypic analysis, A. baumannii had shown resistance against colistin at < 2µg/mL. In contrast, MIC varies from strain to strain. Conclusions: The horizontal transfer of the mcr-1 gene is responsible for developing resistance against colistin among A. baumannii in neonates. All phenotypic methods adopted in this study generated the same results, so the method selection depends upon individual comfort. However, we propose that the colistin agar method offers multiple advantages over other methods as it is more economical, easy to perform, multiple samples can be assessed simultaneously, and fewer calculations are involved for colistin resistance determination and finding out clinical breakpoints.

  • Open Access

    “Investigating mcr Genes in CRAB Isolates during a NICU outbreak and Advancements in Colistin Sensitivity Testing"

    by Mubashir Raza, Saadullah Jan Khan, Muhammad Faisal Masood., Laila Jafri, Rehana Rani, Roomana Ali, Sara Sadiq, Nosheen Aakhtar, Bushra Jamil

    Purpose : Colistin-resistant Acinetobacter baumannii (CRAB) poses a growing challenge in neonatal intensive care units (NICUs) due to the emergence of plasmid-mediated Mobile Colistin Resistance (mcr) genes that can rapidly spread among neonates. This pioneering study conducted a comprehensive analysis of mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5 genes in A. baumannii strains isolated from a Pakistani NICU. Notably, this investigation marks the first of its kind in this setting. In addition to genotypic analyses, the study incorporated phenotypic assays to identify the most effective method for detecting colistin resistance in these A. baumannii strains. The research also encompassed the examination of A. baumannii blood isolates exhibiting low to mid-level colistin resistance during an outbreak in a tertiary care hospital. Methods: In the genotypic investigation, DNA was extracted from strains of colistin-resistant A. baumannii, collected from the NICU of the local hospital of Islamabad, Pakistan. The specific set of primers for each mcr gene was used to detect their presence. Various phenotypic methods such as; disc diffusion, broth macro dilution, Minimum Inhibition Concentration (MIC), disc elusion and colistin agar methods were performed using predetermined calculations for phenotypic studies. Results: The study confirms the distribution of the mcr-1 gene among the eight strains, which contributes 66 % of the total number, whereas mcr-2, 3, 4 and 5 genes were not detected in all strains. Based on phenotypic analysis, A. baumannii had shown resistance against colistin at < 2µg/mL. In contrast, MIC varies from strain to strain. Conclusions: The horizontal transfer of the mcr-1 gene is responsible for developing resistance against colistin among A. baumannii in neonates. All phenotypic methods adopted in this study generated the same results, so the method selection depends upon individual comfort. However, we propose that the colistin agar method offers multiple advantages over other methods as it is more economical, easy to perform, multiple samples can be assessed simultaneously and fewer calculations are involved for colistin resistance determination and finding out clinical breakpoints.

  • Open Access

    “Investigating mcr Genes in CRAB Isolates during a NICU outbreak and Advancements in Colistin Sensitivity Testing"

    by Mubashir Raza, Saadullah Jan Khan, Muhammad Faisal Masood., Laila Jafri, Rehana Rani, Sara Sadiq, Bushra Jamil, Roomana Ali

    Purpose : Colistin-resistant Acinetobacter baumannii (CRAB) poses a growing challenge in neonatal intensive care units (NICUs) due to the emergence of plasmid-mediated Mobile Colistin Resistance (mcr) genes that can rapidly spread among neonates. This pioneering study conducted a comprehensive analysis of mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5 genes in A. baumannii strains isolated from a Pakistani NICU. Notably, this investigation marks the first of its kind in this setting. In addition to genotypic analyses, the study incorporated phenotypic assays to identify the most effective method for detecting colistin resistance in these A. baumannii strains. The research also encompassed the examination of A. baumannii blood isolates exhibiting low to mid-level colistin resistance during an outbreak in a tertiary care hospital. Methods: In the genotypic investigation, DNA was extracted from strains of colistin-resistant A. baumannii, collected from the NICU of the local hospital of Islamabad, Pakistan. The specific set of primers for each mcr gene was used to detect their presence. Various phenotypic methods such as; disc diffusion, broth macro dilution, Minimum Inhibition Concentration (MIC), disc elusion and colistin agar methods were performed using predetermined calculations for phenotypic studies. Results: The study confirms the distribution of the mcr-1 gene among the eight strains, which contributes 66 % of the total number, whereas mcr-2, 3, 4 and 5 genes were not detected in all strains. Based on phenotypic analysis, A. baumannii had shown resistance against colistin at < 2µg/mL. In contrast, MIC varies from strain to strain. Conclusions: The horizontal transfer of the mcr-1 gene is responsible for developing resistance against colistin among A. baumannii in neonates. All phenotypic methods adopted in this study generated the same results, so the method selection depends upon individual comfort. However, we propose that the colistin agar method offers multiple advantages over other methods as it is more economical, easy to perform, multiple samples can be assessed simultaneously and fewer calculations are involved for colistin resistance determination and finding out clinical breakpoints.